Home » Mimetogen Starts Patient Enrollment in Phase III Study of Eye Drug
Mimetogen Starts Patient Enrollment in Phase III Study of Eye Drug
Mimetogen Pharmaceuticals has enrolled its first patients in a Phase III study of MIM-D3 ophthalmic solution for dry eyes.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May